Why is it so important to protect people from HPV?

The latest HPV vaccine, developed by Pfizer, has been widely heralded for its effectiveness in preventing cervical cancer, as well as other cancers that are also associated with the virus.

But the vaccine has also been criticised for having a high side effect rate, particularly for the elderly and people with compromised immune systems.

Dr Farley, who is a medical advisor to the World Health Organisation and is based at the University of Sydney, said the vaccine had been marketed to be given to people aged over 55 for the first time, so it was time to look at whether it was also safe and effective for younger people.

Dr Ravi R. Farley is a clinical scientist and associate professor of paediatric and clinical genetics at the Queensland Institute of Health Sciences.

He is one of the authors of a paper published in The Lancet journal on Tuesday that questioned whether HPV vaccination should be given only to people who have had previous infection with the HPV 16 variant of the virus, which can cause cervical cancer.

Dr. Farly said there was little research into the effect of vaccination on cervical cancer incidence.

“What we’ve done is looked at the incidence of cervical cancer in the general population and we’ve seen that the rate of HPV 16 cases is higher than the rate in the population at large,” Dr Farley said.

“We don’t know if that’s because there’s a higher incidence in women or if it’s because of the HPV vaccine.”

In his paper, Dr Farly wrote that “vaccine efficacy is highly variable”.

“The evidence is not robust and the vaccine is currently not available for use in the US, Australia, Canada or New Zealand.”

In the US alone, the vaccine was given to about 1.3 million people aged between 15 and 64.

Dr John C. DeKeseredy, an epidemiologist at the American Cancer Society, said it was important to take the vaccine with a grain of salt.

“It’s important to look carefully at the side effects and how well the vaccine works, and it’s important not to rush it to people before we can get a full picture of how it works,” Dr DeKersedy said.

He said there is no evidence that the vaccine can protect against cervical cancer at the population level.

“People are already getting vaccinated against HPV,” Dr Deskedy said, adding that in Australia, the population vaccination rate is lower than that in the United States.

“There’s not a lot of research done on this so it’s difficult to draw any conclusions.”